) ... vehicle gel (p<0.0003). ● Actinic keratosis (AK) is the most common skin condition diagnosed by US dermatologists1. ● If left untreated, AK may progress to squamous cell carcinoma2,3. WOBURN, Mass. (February 9, 2026) - Biofrontera Inc. (Nasdaq ... 2 ... 3.
). Biofrontera Inc ... ● Q4 year-over-year growth of 35% to 39% driven by sales execution of Ameluz®. ● Full year 2025 revenues also expected to show double-digit growth of 11% to 13%. WOBURN, Mass. (January 13, 2026) - Biofrontera Inc. (Nasdaq... Ben Shamsian.
To regain compliance, during this 180-day compliance period, the closing bid price of the Company's common stock must be at least $1.00 per share for a minimum of 10 consecutive business days ...AttachmentsOriginal document Permalink. Disclaimer ... (noodl.
10.1111/j.1524-4725.2007.33224.x ... doi.10.1111/jdv.13180 ... DOI 10.1111/bjd ... The purchase price for the Acquired Assets (as defined in the APA) is a maximum of $10,000,000, payable as follows ... 10 ... 10.3# Amendment No ... 10.29 Amendment No.
Conference call will be held today, Thursday, November 13 at 10.00 am ET ... Selling, general and administrative expenses were $10.4 million for the third quarter of 2025 compared with $8.4 million for the third quarter of 2024.
Certain statements in this Form 10-Q constitute "forward-looking statements" ... The purchase price for the acquired assets is a maximum of $10.0 million, payable as follows ... Selling, general and administrative 10,047 8,425 1,622 ... See Note 10.
This groundbreaking vision is now reality as immortality startup Eternos transforms into Uare.ai, securing $10.3 million in seed funding to revolutionize how we think about personal AI and digital preservation ...Feature Uare.ai Traditional AI Chatbots.
published this content on November 10, 2025, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on November 10, 2025 at 21.37 UTC.
for up to $10M ● Proceeds of up to $10 million, consisting of $3 million at closing, $1 million upon availability of commercial product, and up to $6 million in sales-related milestone payments.